Latest Breaking News On - Adrienne kemp - Page 3 : comparemela.com

Tarsus Announces Pricing of $100 0 Million Public Offering

IRVINE, Calif., March 01, 2024 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,.

United statesNorth carolinaNew yorkDavid nakasoneAdrienne kempGoldman sachs coEquity syndicate departmentCorporate communicationsSyndicate prospectus departmentOppenheimer coProspectus departmentTarsus pharmaceuticals incCompany or tarsusExchange commissionGuggenheim securitiesBofa securities

Tarsus Announces Proposed $100 0 Million Public Offering

IRVINE, Calif., Feb. 29, 2024 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,.

North carolinaUnited statesNew yorkAdrienne kempDavid nakasoneExchange commissionSyndicate prospectus departmentProspectus departmentOppenheimer coGoldman sachs coCorporate communicationsTarsus pharmaceuticals incCompany or tarsusEquity syndicate departmentGuggenheim securitiesBofa securities

Tarsus Announces Proposed $100 0 Million Public Offering

Tarsus Announces Proposed $100 0 Million Public Offering
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesNew yorkAdrienne kempDavid nakasoneCompany or tarsusEquity syndicate departmentGuggenheim securitiesExchange commissionSyndicate prospectus departmentOppenheimer coGoldman sachs coTarsus pharmaceuticals incProspectus departmentCorporate communicationsBofa securities

Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements

Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAdrienne kempDavid nakasoneBobak azamianCorporate communicationsExchange commissionTarsus pharmaceuticals incChief executive officerBusiness highlightsCare providersMeibomian gland diseasePapulopustular rosaceaImportant safetyTarsus pharmaceuticalsElanco tiergesundheitTarsu form

Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept Tick-Kill Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease -February 22, 2024 at 08:03 am EST

TP-05 demonstrated tolerability and statistically significant tick mortality, suggesting potential for on-demand Lyme disease prophylaxisIRVINE, Calif., Feb. 22, 2024 Tarsus Pharmaceuticals,.

United statesAdrienne kempDavid nakasoneCenters for diseaseExchange commissionCorporate communicationsTarsus pharmaceuticals incDisease controlTarsus pharmaceuticalsMeibomian gland diseaseTarsu formLyme disease